KCT0000161已完成未知
A single dose, sequence-randomized, open-label, 2x2 crossover study to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo complex product in healthy male subjects
JW Pharmaceutical0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 55(Year)（—）
- 性别
- Male
入选标准
- •Healthy male volunteers
- •Age 20-55 years at the time of Screening
- •BMI 19-26 kg/m2 at the time of Screening
排除标准
- •Received other investigational drug within 90 days prior to the first dose of study drug
研究者
相似试验
招募中
不适用
The pharmacokinetic characteristics and safety of Rap18001 in postmenopausal femaleDiseases of the musculo-skeletal system and connective tissueKCT0004153Chonbuk National University Hospital6
已完成
Unknown
Phase 1 study to evaluate the safety and pharmacokinetics comparison of AD-104 in healthy adult volunteersKCT0009332Addpharma40
已完成
不适用
An open-label, randomized, single-dose, 2-sequence, 2-period, cross-over phase 1 study under fasting state to evaluate the safety and pharmacokinetics of DKB19003” in healthy adult volunteersKCT0006103Dongkoo Bio & Pharma40
已完成
Unknown
Phase 1 study to Evaluate the Effect of Food on Investigational Product(AD-109) in Healthy Adult VolunteersKCT0009335Addpharma36
已完成
不适用
An open-label, randomized, single-dose, 2-sequence, 2-period, cross-over phase 1 study under fed state to evaluate the safety and pharmacokinetics of DKB19003” in healthy adult volunteersKCT0006104Dongkoo Bio & Pharma40